John Philip Coghlan - 03 Aug 2026 Form 4 Insider Report for Life360, Inc. (LIF)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
05 Aug 2026, 17:10:47 UTC
Prior SEC filing
06 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jay Sood, as Attorney-in-Fact

Key filing fact

John Philip Coghlan filed Form 4 for Life360, Inc. (LIF) on 05 Aug 2026.

Key facts

  • This page summarizes John Philip Coghlan's Form 4 filing for Life360, Inc. (LIF).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 05 Aug 2026, 17:10.

Change

  • Previous filing in this sequence was filed on 06 Jul 2026.
  • Current net transaction value: -$219,264.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001185999 Primary reporting owner

COGHLAN JOHN PHILIP

Relationship
Director
Address
C/O LIFE360, INC., 1900 SOUTH NORFOLK STREET, SUITE 310, SAN MATEO
Signature
/s/ Jay Sood, as Attorney-in-Fact
Signature date
05 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LIF transaction

Common stock

Sale

Transaction value
$76,524
Shares
-1,400
Change %
-5.7%
Price
$54.66
Shares after
23,031
Date
03 Aug 2026
Ownership
Held by the John Coghlan Living Trust
Footnotes
F1, F2
LIF transaction

Common stock

Sale

Transaction value
$142,740
Shares
-2,600
Change %
-11%
Price
$54.90
Shares after
20,431
Date
03 Aug 2026
Ownership
Held by the John Coghlan Living Trust
Footnotes
F1, F3
LIF holding

Common stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,676
Date
03 Aug 2026
Ownership
Direct
Footnotes
F4
LIF holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
55,494
Date
03 Aug 2026
Ownership
Held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.

Footnote F2

The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $53.83 to $54.80, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

Footnote F3

The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $54.89 to $54.95, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

Footnote F4

Includes 4,840 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .